CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $43,888 | -33.5% | 397,168 | 0.0% | 0.01% | -15.4% |
| Q3 2022 | $66,000 | -69.6% | 397,168 | -54.0% | 0.01% | -67.5% |
| Q2 2022 | $217,000 | -59.1% | 862,527 | -13.5% | 0.04% | -42.9% |
| Q1 2022 | $530,000 | -9.2% | 997,627 | +5.2% | 0.07% | -19.5% |
| Q4 2021 | $584,000 | -39.7% | 948,526 | 0.0% | 0.09% | +27.9% |
| Q3 2021 | $968,000 | -45.1% | 948,526 | -1.6% | 0.07% | -52.4% |
| Q2 2021 | $1,764,000 | -7.1% | 964,100 | 0.0% | 0.14% | +123.4% |
| Q1 2021 | $1,899,000 | +991.4% | 964,100 | +593.1% | 0.06% | +700.0% |
| Q4 2020 | $174,000 | -56.2% | 139,100 | -36.8% | 0.01% | -72.4% |
| Q3 2020 | $397,000 | -98.0% | 220,100 | -90.6% | 0.03% | -98.2% |
| Q2 2020 | $19,717,000 | – | 2,350,000 | – | 1.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |